|
Real-time
Euronext Bruxelles
16:17:06 30/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 281.80 EUR | +0.64% |
|
+3.45% | +18.23% |
| 10-27 | AlphaValue/Baader Europe Raises Estimates for UCB on Recent FY26 Outlook Upgrade | MT |
| 10-27 | UCB: Undercommit and overdeliver – The UCB way |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UCB | Biopharmaceuticals | +0.64% | +3.45% | +18.23% | +18.73% | +174.02% | 59.6B |  | | |
- Stock Market
- Stocks
- UCB Stock
- Charts UCB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
